Vanda Pharmaceuticals
VNDA
#7543
Rank
HK$3.10 B
Marketcap
HK$52.53
Share price
11.39%
Change (1 day)
46.89%
Change (1 year)

Earnings for Vanda Pharmaceuticals (VNDA)

Earnings in 2025 (TTM): -HK$0.95 Billion

According to Vanda Pharmaceuticals's latest financial reports the company's current earnings are HK$0.21 Billion. In 2024 the company made an earning of -HK$0.32 Billion a decrease over its 2023 earnings that were of -HK$0.11 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vanda Pharmaceuticals from 2005 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -HK$0.95 Billion198.55%
2024 -HK$0.32 Billion191.43%
2023 -HK$0.11 Billion-320.45%
2022 HK$49.25 M-84.99%
2021 HK$0.32 B54.8%
2020 HK$0.21 B19.42%
2019 HK$0.17 B4.93%
2018 HK$0.16 B-228.6%
2017 -HK$0.14 Billion-8.98%
2016 -HK$0.15 Billion-53.79%
2015 -HK$0.32 Billion-30.18%
2014 -HK$0.45 Billion173.08%
2013 -HK$0.17 Billion-25.33%
2012 -HK$0.22 Billion163.61%
2011 -HK$83.33 Million-221.15%
2010 HK$68.77 M-124.53%
2009 -HK$0.29 Billion-29.44%
2008 -HK$0.4 Billion-36.2%
2007 -HK$0.63 Billion21.81%
2006 -HK$0.52 Billion170.55%
2005 -HK$0.19 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
HK$127.77 B-13,658.89%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
HK$175.12 B-18,683.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
HK$252.10 B-26,852.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$62.51 B-6,733.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$92.23 B-9,887.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
-HK$21.83 Million-97.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$179.68 B-19,167.83%๐Ÿ‡บ๐Ÿ‡ธ USA